Descriptor English: | Indomethacin | ||||
Descriptor Spanish: |
Indometacina
| ||||
Descriptor Portuguese: | Indometacina | ||||
Descriptor French: | Indométacine | ||||
Entry term(s): |
Amuno Indocid Indocin Indomet 140 Indometacin Indomethacin Hydrochloride Metindol Osmosin |
||||
Tree number(s): |
D03.633.100.473.420 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007213 | ||||
Scope note: | A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Anti-Inflammatory Agents, Non-Steroidal Cardiovascular Agents Gout Suppressants Tocolytic Agents Cyclooxygenase Inhibitors |
||||
Registry Number: | XXE1CET956 | ||||
CAS Type 1 Name: | 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- | ||||
Public MeSH Note: | 1966 |
||||
History Note: | 1966 (1964) |
||||
DeCS ID: | 28146 | ||||
Unique ID: | D007213 | ||||
NLM Classification: | QV 95 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2018/04/10 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Indomethacin
- Preferred
Osmosin
- Narrower
Indocid
- Narrower
Metindol
- Narrower
Indomet 140
- Narrower
Indomethacin Hydrochloride
- Narrower
Amuno
- Narrower
Indocin
- Narrower
Concept UI |
M0011240 |
Scope note | A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. |
Preferred term | Indomethacin |
Entry term(s) |
Indometacin |
Concept UI |
M0011241 |
Preferred term | Osmosin |
Concept UI |
M0011242 |
Preferred term | Indocid |
Concept UI |
M0353732 |
Preferred term | Metindol |
Concept UI |
M0353733 |
Preferred term | Indomet 140 |
Concept UI |
M0330169 |
Preferred term | Indomethacin Hydrochloride |
Concept UI |
M0353728 |
Preferred term | Amuno |
Concept UI |
M0353731 |
Preferred term | Indocin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey